ATE71843T1 - Behandlung des atemunwohlseinsyndroms bei erwachsenen. - Google Patents

Behandlung des atemunwohlseinsyndroms bei erwachsenen.

Info

Publication number
ATE71843T1
ATE71843T1 AT86902635T AT86902635T ATE71843T1 AT E71843 T1 ATE71843 T1 AT E71843T1 AT 86902635 T AT86902635 T AT 86902635T AT 86902635 T AT86902635 T AT 86902635T AT E71843 T1 ATE71843 T1 AT E71843T1
Authority
AT
Austria
Prior art keywords
syndrome
wellbeing
adults
respiratory
treatment
Prior art date
Application number
AT86902635T
Other languages
English (en)
Inventor
Thomas A Raffin
John H Stevens
Original Assignee
Thomas A Raffin
John H Stevens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas A Raffin, John H Stevens filed Critical Thomas A Raffin
Application granted granted Critical
Publication of ATE71843T1 publication Critical patent/ATE71843T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT86902635T 1985-04-02 1986-03-31 Behandlung des atemunwohlseinsyndroms bei erwachsenen. ATE71843T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/718,918 US4686100A (en) 1985-04-02 1985-04-02 Method for the treatment of adult respiratory distress syndrome
EP86902635A EP0219524B1 (de) 1985-04-02 1986-03-31 Behandlung des atemunwohlseinsyndroms bei erwachsenen
PCT/US1986/000659 WO1986005692A2 (en) 1985-04-02 1986-03-31 Treatment of adult respiratory distress syndrome

Publications (1)

Publication Number Publication Date
ATE71843T1 true ATE71843T1 (de) 1992-02-15

Family

ID=24888089

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86902635T ATE71843T1 (de) 1985-04-02 1986-03-31 Behandlung des atemunwohlseinsyndroms bei erwachsenen.

Country Status (6)

Country Link
US (1) US4686100A (de)
EP (1) EP0219524B1 (de)
JP (1) JPS62502616A (de)
AT (1) ATE71843T1 (de)
DE (1) DE3683586D1 (de)
WO (1) WO1986005692A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147637A (en) * 1988-06-07 1992-09-15 The Rockefeller University Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma
US4966137A (en) * 1989-09-19 1990-10-30 Davini Mark A Splint system
US5322699A (en) * 1991-02-04 1994-06-21 The Rockefeller University Leukocyte-derived CR3 modulator, integrin modulating factor-1 (IMF-1)
EP0523856A3 (en) * 1991-06-28 1993-03-17 Sgs-Thomson Microelectronics, Inc. Method of via formation for multilevel interconnect integrated circuits
WO1993011784A1 (en) * 1991-12-13 1993-06-24 Duke University Methods for inhibition or stimulation of the inflammatory response
US5837499A (en) * 1993-12-06 1998-11-17 Ciba-Geigy Corporation DNA encoding C5A receptor antagonists having substantially no agonist activity and methods of expressing same
US5807824A (en) * 1993-12-06 1998-09-15 Ciba-Geigy Corporation C5A receptor antagonists having substantially no agonist activity
EP0751787B1 (de) * 1994-03-23 2005-01-12 Alexion Pharmaceuticals, Inc. Verfahren zur reduktion von fehlfunktionen des immunsystems und der hämostase während des extrakorporalen kreislaufs
US5504090A (en) * 1994-03-30 1996-04-02 Trustees Of The University Of Pennsylvania Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury
US6074642A (en) 1994-05-02 2000-06-13 Alexion Pharmaceuticals, Inc. Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
US5504111A (en) * 1994-12-30 1996-04-02 Medichem Research, Inc. Use of 2,3 alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
AU2213197A (en) * 1996-03-05 1997-09-22 Medinox, Inc. Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
US6673346B1 (en) * 1999-08-31 2004-01-06 The Regents Of The University Of Michigan Compositions and methods for the treatment of sepsis
CA2457461C (en) * 2001-08-17 2013-12-24 Tanox, Inc. Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b
EP3372243A1 (de) 2001-08-17 2018-09-12 Genentech, Inc. Komplement-inhibitoren, die an c5 und c5a binden, ohne die bildung von c5b zu hemmen
ES2614274T3 (es) 2002-09-06 2017-05-30 Alexion Pharmaceuticals, Inc. Procedimiento de tratamiento de asma usando anticuerpos frente al componente de complemento C5
US20050169921A1 (en) 2004-02-03 2005-08-04 Leonard Bell Method of treating hemolytic disease
US20070116710A1 (en) * 2004-02-03 2007-05-24 Leonard Bell Methods of treating hemolytic anemia
US20070196367A1 (en) * 2006-02-22 2007-08-23 Valentin Dinu Methods of preventing and treating Alzheimer's disease, age related macular degeneration and other diseases involving extra-cellular debris through the inhibition of the complement system
ES2965283T3 (es) 2006-03-15 2024-05-28 Alexion Pharma Inc Tratamiento de pacientes con hemoglobinuria paroxística nocturna mediante un inhibidor del complemento
US9447176B2 (en) 2008-11-10 2016-09-20 Alexion Pharmaceuticals, Inc. Methods and compositions for treating complement-associated disorders
SMT202200074T1 (it) 2008-12-22 2022-03-21 Chemocentryx Inc Antagonisti di c5ar
JP6022441B2 (ja) 2010-04-30 2016-11-09 アレクシオン ファーマシューティカルズ， インコーポレイテッド 抗Ｃ５ａ抗体およびその抗体の使用のための方法
HRP20171176T1 (hr) 2010-06-24 2017-10-06 Chemocentryx, Inc. C5ar antagonisti
EP2468295A1 (de) 2010-12-21 2012-06-27 Affiris AG Impfstoffe basierend auf Komplementprotein C5a Peptide
SI3011345T1 (sl) 2013-08-07 2017-12-29 Alexion Pharmaceuticals, Inc. Biomarkerski proteini za atipični hemolitični uremični sindrom (ahus)
EP3682879B1 (de) 2014-09-29 2022-08-03 ChemoCentryx, Inc. Verfahren und zwischenprodukte in der herstellung von c5ar-inhibitoren
MX2022006069A (es) 2016-01-14 2023-01-12 Chemocentryx Inc Metodo para tratar glomerulopatia c3.
WO2017218515A1 (en) 2016-06-14 2017-12-21 Regeneron Pharmaceuticals, Inc. Anti-c5 antibodies and uses thereof
MX2020006113A (es) 2017-12-13 2020-08-24 Regeneron Pharma Combinaciones de anticuerpos anti-c5 y usos de las mismas.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3407M (fr) * 1964-03-25 1965-07-05 Michel Plissier Immunoglobulines anti-antigenes microbiens et viraux, seules ou associées, utilisées dans la prévention et le traitement des syndromes infectieux respiratoires.

Also Published As

Publication number Publication date
WO1986005692A2 (en) 1986-10-09
US4686100A (en) 1987-08-11
EP0219524A1 (de) 1987-04-29
DE3683586D1 (de) 1992-03-05
JPS62502616A (ja) 1987-10-08
EP0219524B1 (de) 1992-01-22

Similar Documents

Publication Publication Date Title
DE3683586D1 (de) Behandlung des atemunwohlseinsyndroms bei erwachsenen.
DE69020582D1 (de) Verwendung von Melatonin zur Behandlung des prämenstruellen Syndroms.
ATE258065T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen
DE69132688D1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE3482405D1 (de) Saugfaehiges wergwerferzeugnis mit vereinigten wirkstoffen zur behandlung und prophylaxe von windelausschlag und windeldermatitis.
EP0199479A3 (en) Ozone decontamination of blood and blood products
DE3684409D1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
NL970045I1 (nl) Desulfatohirudinen, werkwijze voor hun bereiding en farmaceutische middelen.
ATE168268T1 (de) Behandlung von menschlichen retrovirus- infektionen mit 2',3'-dideoxyinosin
DE69226877D1 (de) Behandlung der hiv-assoziierten immun-thrombopenie purpura
RU94020410A (ru) Способ лечения или профилактики рвоты у млекопитающих и человека с использованием некоторых хинуклидиновых, пиперидиновых, азанорборнановых, этилендиаминовых производных и родственных им соединений
NO901141D0 (no) Additiv og fremgangsmaate for behandling av underjordiske formasjoner.
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
IT8548055A1 (it) Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
NO890046D0 (no) Disubstituerte pyridiner.
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
DE3879837D1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
ATE235238T1 (de) Verwendung von 2,3- alkylcaebonyloxybenzoesäure zur behandlung des atemunwohlseinsydroms bei erwachsenen
SU127202A1 (ru) Способ лечени л мблиоза людей
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus
PT86794A (pt) Process for the preparation of compositions for the treatment of wood and processes of treating wood
EP0343258A4 (de) Mittel zur prophylaxe und behandlung von viralen infektionskrankheiten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties